RxDoctor Payments Data

Anthony Jackson, MD

Family Medicine · Hutchinson, KSNPI 1366413114

Payments from drug & device makers

$1,662in general payments, 2019–2025

Across 123 payments — averaging $13.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$562
  • Amgen$289
  • AbbVie$239
  • Pfizer$84
  • Sumitomo Pharma America, Inc.$68
  • GSK$64
  • plus $355 from 15 others

What the payments were for

  • Food & beverage$1,662100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,662 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$9,500
Medicare patients
175
Services billed
465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide79$110,514
EliquisApixaban143$91,251
TrulicityDulaglutide62$65,119
XareltoRivaroxaban70$61,420
MounjaroTirzepatide45$51,385
JardianceEmpagliflozin50$41,988
LinzessLinaclotide58$41,330
FarxigaDapagliflozin Propanediol50$32,881
MyrbetriqMirabegron72$30,895
Tresiba Flextouch U-200Insulin Degludec30$21,609
GemtesaVibegron34$18,785
RybelsusSemaglutide12$18,719
JanuviaSitagliptin Phosphate25$12,783
JanumetSitagliptin Phos/Metformin Hcl13$9,122
Emgality PenGalcanezumab-Gnlm13$9,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$562$129,23391 claims
Lilly USA, LLCTrulicity, Mounjaro$15$116,505107 claims
PfizerEliquis$84$91,251143 claims
Johnson & JohnsonXarelto$26$61,42070 claims
AbbVieLinzess, Synthroid$239$44,433101 claims
AstraZenecaFarxiga$15$32,88150 claims
Astellas Pharma US IncMyrbetriq$17$30,89572 claims
MerckJanuvia, Janumet$15$21,90538 claims
Sumitomo Pharma America, Inc.Gemtesa$68$18,78534 claims
GSKBreo Ellipta, Anoro Ellipta$64$10,31825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Hutchinson

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →